Two Sigma Advisers’s Organogenesis Holdings ORGO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-357,500
| Closed | -$1.54M | – | 2474 |
|
|
2025
Q1 | $1.54M | Sell |
357,500
-131,500
| -27% | -$568K | ﹤0.01% | 1263 |
|
|
2024
Q4 | $1.56M | Sell |
489,000
-58,400
| -11% | -$187K | ﹤0.01% | 1244 |
|
|
2024
Q3 | $1.57M | Sell |
547,400
-69,200
| -11% | -$198K | ﹤0.01% | 1202 |
|
|
2024
Q2 | $1.73M | Sell |
616,600
-197,800
| -24% | -$554K | ﹤0.01% | 1267 |
|
|
2024
Q1 | $2.31M | Sell |
814,400
-63,500
| -7% | -$180K | 0.01% | 1143 |
|
|
2023
Q4 | $3.59M | Sell |
877,900
-104,300
| -11% | -$427K | 0.01% | 971 |
|
|
2023
Q3 | $3.12M | Sell |
982,200
-63,300
| -6% | -$201K | 0.01% | 960 |
|
|
2023
Q2 | $3.47M | Sell |
1,045,500
-39,500
| -4% | -$131K | 0.01% | 930 |
|
|
2023
Q1 | $2.31M | Buy |
1,085,000
+222,100
| +26% | +$473K | 0.01% | 1202 |
|
|
2022
Q4 | $2.32M | Sell |
862,900
-420,800
| -33% | -$1.13M | 0.01% | 1155 |
|
|
2022
Q3 | $4.16M | Buy |
1,283,700
+361,800
| +39% | +$1.17M | 0.01% | 825 |
|
|
2022
Q2 | $4.5M | Buy |
921,900
+72,500
| +9% | +$354K | 0.01% | 823 |
|
|
2022
Q1 | $6.47M | Sell |
849,400
-145,400
| -15% | -$1.11M | 0.02% | 690 |
|
|
2021
Q4 | $9.19M | Buy |
994,800
+66,800
| +7% | +$617K | 0.02% | 527 |
|
|
2021
Q3 | $13.2M | Buy |
928,000
+208,800
| +29% | +$2.97M | 0.03% | 437 |
|
|
2021
Q2 | $12M | Buy |
719,200
+406,200
| +130% | +$6.75M | 0.03% | 497 |
|
|
2021
Q1 | $5.7M | Buy |
313,000
+254,300
| +433% | +$4.63M | 0.02% | 806 |
|
|
2020
Q4 | $442K | Buy |
+58,700
| New | +$442K | ﹤0.01% | 1911 |
|
|
2020
Q3 | – | Sell |
-52,900
| Closed | -$203K | – | 2574 |
|
|
2020
Q2 | $203K | Sell |
52,900
-3,500
| -6% | -$13.4K | ﹤0.01% | 2246 |
|
|
2020
Q1 | $182K | Buy |
56,400
+23,500
| +71% | +$75.8K | ﹤0.01% | 2193 |
|
|
2019
Q4 | $158K | Buy |
+32,900
| New | +$158K | ﹤0.01% | 2222 |
|